FeelGood vs Hers: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Hers beats FeelGood overall, scoring 7.3/10 vs 7/10. FeelGood is more affordable at $149/mo vs $199/mo. Choose FeelGood for budget-conscious cash-pay patients who want low-cost compoun. Choose Hers for women who want brand-name wegovy (injection or pill) at $149.
A side-by-side look at FeelGood and Hers to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
FeelGood
#47 of 53Telehealth platform offering compounded semaglutide as both a weekly injection ($149/mo starting) and a daily oral tablet ($249/mo starting), plus a premium brand-name 'original' semaglutide injection option ($1,999/mo). Cash-pay only, no insurance billing, HSA/FSA eligible. LegitScript-approved. FeelGood does not publicly disclose which states it serves, its compounding pharmacy, or its medical leadership.
Visit FeelGoodHers
#34 of 53The women's health arm of Hims & Hers Health (NYSE: HIMS). In 2026 Hers signed a direct Novo Nordisk partnership adding FDA-approved Wegovy (pen and pill) at $149/mo and Zepbound via the Lilly partnership, alongside their existing compounded semaglutide and new compounded tirzepatide programs.
Visit Hers| Feature | FeelGood | Hers |
|---|---|---|
| Our Score | 7/10 | 7.3/10 |
| Starting Price | $149/mo | $199/mo |
| Medication Type | Both | Both |
| Insurance Accepted | No | No |
| Best For | Budget-conscious cash-pay patients who want low-cost compounded semaglutide, injection or oral tablet, with free shipping, no membership fees, and a money-back weight-loss guarantee | Women who want brand-name Wegovy (injection or pill) at $149/mo via the 2026 Novo Nordisk partnership, or a compounded semaglutide option from a publicly traded telehealth brand |
| Ranking | #47 | #34 |
| Get started | Visit FeelGood | Visit Hers |
Pros & Cons Compared
FeelGood
Pros
- +Compounded semaglutide injection from $149/mo with free shipping and no separate membership or consultation fee
- +Offers an oral compounded semaglutide tablet ($249/mo) for needle-averse patients, a non-injectable route only a handful of platforms provide
- +LegitScript-approved, independent certification that the telehealth/pharmacy operation meets legal and safety standards, which many budget compounded shops lack
- +Money-back weight-loss guarantee plus unlimited 24/7 messaging and appointments included
Cons
- −Does NOT publicly disclose which US states it serves, you can't confirm availability in your state before starting an intake
- −$149 is a 'starting' price (dose-escalating), not flat across all doses, your cost can rise as your dose titrates up, and FeelGood doesn't publish the full dose-by-dose schedule
- −Brand-name 'original' semaglutide injection at $1,999/mo is far above market, NovoCare direct Wegovy is $349/mo and Hers offers Wegovy at $149/mo via the 2026 Novo Nordisk partnership. Never buy brand-name through FeelGood
- −No named medical director, prescribing physicians, compounding pharmacy, founding year, or headquarters disclosed on the site, thin corporate and clinical transparency
- −Self-reported '4.8/5' rating is not tied to a named third-party platform (no linked Trustpilot/BBB), so it can't be independently verified; the advertised '15–20% weight loss' figures are FeelGood's marketing, not FDA-reviewed efficacy data
- −Compounded GLP-1s are not FDA-approved (none are), and FeelGood offers compounded semaglutide only, no tirzepatide
Hers
Pros
- +2026 Novo Nordisk partnership, FDA-approved Wegovy pen and Wegovy oral pill from $149/mo, one of the lowest brand-name GLP-1 prices on the market
- +Zepbound access via the Lilly/Hims-Hers partnership announced 2026
- +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
- +Broader women's health platform, integrates weight loss with hormonal, skin, and wellness services
Cons
- −Membership + medication are billed separately ($39 first month / $149 ongoing membership), so total both line items before comparing prices
- −Support runs at big-platform scale, fine for routine refills, less personal if you want high-touch care
- −Compounded pricing starts at $199/mo with stepped pricing at higher doses, budget for the dose you'll end up on, not the entry dose
- −Zepbound access priced at ~$1,899/mo (brand cash) via the Lilly partnership, read as access, not value
Our Verdict
Hers edges out FeelGood with a score of 7.3/10 vs 7/10. If budget is your priority, FeelGood starts at $149/mo compared to Hers's $199/mo. Choose FeelGood if you want: budget-conscious cash-pay patients who want low-cost compounded semaglutide, injection or oral tablet, with free shipping, no membership fees, and a money-back weight-loss guarantee. Choose Hers if you want: women who want brand-name wegovy (injection or pill) at $149/mo via the 2026 novo nordisk partnership, or a compounded semaglutide option from a publicly traded telehealth brand.
Still undecided? Editor's Featured Pick
TrimRx
$149/mo · 7.8/10 · Compounded
If neither FeelGood nor Hers feels like the right fit, our featured pick across all 53 GLP-1 telehealth providers is TrimRx. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $149/mo that stays the same at every dose.
Read Full Reviews
Related comparisons
Other matchups readers comparing FeelGood or Hers tend to look at next.
- FeelGood vs MEDVi$179/mo
- FeelGood vs bmiMD$119/mo
- FeelGood vs Found$129/mo
- Hers vs Sprout Health$199/mo
- Hers vs Enhance MD$212/mo
- Hers vs MEDVi$179/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.